Directors’ Dealings | 8 June 2010 20:34

DGAP-DD: STRATEC Biomedical Systems AG english

Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors’ Dealings notification transmitted by DGAP – a company of EquityStory AG. The person with duty of notification is solely responsible for the content of this announcement. —————————————————————————— Details of the person subject to the disclosure requirement Last name: Steidle First name: Bernd M. Position: Member of a managing body Information about the transaction with duty of notification Description of the financial instrument: STRATEC Biomedical Systems AG / Ordinary Share ISIN/WKN of the financial instrument: DE0007289001 Type of transaction: Sale Date: 01.06.2010 Price: 25.317 Currency: EUR No. of items: 10000 Total amount traded: 253170.00 Place: außerbörslich / OTC Explanation for publication: Cashless exercise (exercising of stock options incl. block sale of stocks to bank; strike price for underlying stock options: Euro 22.69) Information about the company with duty of publication Issuer: STRATEC Biomedical Systems AG Gewerbestraße 37 75217 Birkenfeld Deutschland ISIN: DE0007289001 WKN: 728900 End of Directors’ Dealings Notification (c) DGAP 08.06.2010 Ad hoc announcement, Financial News and Media Release distributed by DGAP. Media archive at www.dgap-medientreff.de and www.dgap.de ID 11476